National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 37469-37470 [E8-14839]

Download as PDF Federal Register / Vol. 73, No. 127 / Tuesday, July 1, 2008 / Notices copies of each report shall be submitted to FDA’s Grants Management Office (see section VI of this document). A Mid-Year Progress Report is also required no later than 90 days after the close of the budget period. The MidYear Progress Report should cover 6 months of activity. Program monitoring of recipients will be conducted on an ongoing basis and written reports will be reviewed and evaluated at least semi-annually by the project officer. Project monitoring may also be in the form of telephone conversations between the project officer/grants management specialist and the principal investigator. When multiple years are involved, awardees will be required to submit the PHS Non-Competing Grant Progress Report (PHS 2590) https://grants.nih.gov/ grants/funding/2590/2590.htm annually and financial statements as required in the Department of Health and Human Services Grants Policy Statement. Reports must be submitted two months prior to the next budget period start date. The Progress Report should include a report of the previous meeting supported by the current grant, as well as a full description of the next planned meeting. VI. Agency Contacts We encourage your inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants. Inquiries may fall into two areas: Scientific/research and financial or grants management issues: sroberts on PROD1PC70 with NOTICES A. Scientific/Research Contacts Regarding the programmatic issues of this notice: Jennifer Gabb, Division of Federal-State Relations, Office of Regulatory Affairs (HFC–150), Food and Drug Administration, 5600 Fishers Lane, rm. 12–07, Rockville, MD 20857, 301–827–2899, e-mail: jennifer.gabb@fda.hhs.gov, or access the Internet at https:// www.fda.gov/ora/fed_state/ default.htm. For general Food Defense program information: Don Kautter, Center for Food Safety and Applied Nutrition (HFS–007), 5100 Paint Branch, rm. 3B019, College Park, MD, 20740, 301–436–1629, e-mail: donald.kautter@fda.hhs.gov, or access the Internet at: https:// www.cfsan.fda.gov/~dms/ defterr.html. B. Financial or Grants Management Contacts Regarding the administrative and VerDate Aug<31>2005 21:01 Jun 30, 2008 Jkt 214001 financial management issues of this notice: Marc Pitts, Office of Acquisitions & Grants Services, Grants Acquisition and Assistance Team (HFA–500), Food and Drug Administration, rm. 2104, 5630 Fishers Lane, Rockville, MD 20857; e-mail: marc.pitts@fda.hhs.gov. Dated: June 25, 2008. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E8–14876 Filed 6–30–08; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Review of Applications for RFA: International Research on Venue-Based Interventions for HIV/AIDS and Alcohol Use. Date: July 16–18, 2008 Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jose H. Guerrier, PhD., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301–435– 1137, guerriej@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Infectious Diseases Microbiology Fellowships. Date: July 17, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 37469 Place: Avenue Hotel Chicago, 160 Huron Street, Chicago, Il 60611. Contact Person: Alexander D. Politis, PhD., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 20892, (301) 435– 1150, politisa@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Addictions, Pathways and Prevention. Date: July 23–24, 2008. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Michael Micklin, PhD., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3136, Bethesda, MD 20892, (301) 435–1258, micklinm@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 24, 2008. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–14837 Filed 6–30–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special E:\FR\FM\01JYN1.SGM 01JYN1 37470 Federal Register / Vol. 73, No. 127 / Tuesday, July 1, 2008 / Notices Emphasis Panel; Operation of a Facility for the Study of Infectious Agents, Vaccines and Antimicrobials in Adult and Pediatric Human Subjects. Date: July 21, 2008. Time: 9 a.m. to 12 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Lynn Rust, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301– 402–3938, lr228v@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: June 24, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–14839 Filed 6–30–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services [CIS No. 2423–08; DHS Docket No. USCIS 2008–0031] RIN 1615–ZA60 Small Business Non-Retaliation Policy U.S. Citizenship and Immigration Services, DHS. ACTION: Notice. sroberts on PROD1PC70 with NOTICES AGENCY: SUMMARY: In support of the initiatives of the National Ombudsman of the U.S. Small Business Administration, U.S. Citizenship and Immigration Services (USCIS) announces adoption of a small business non-retaliation policy. If a small business questions or lodges a complaint regarding a USCIS policy or action or seeks help from others to deal with such a policy or action, USCIS will not retaliate against that small business in any fashion. The full policy is established by this notice. DATES: The Acting Director of USCIS approved the small business nonretaliation policy on June 24, 2008. The policy remains in effect until modified or rescinded by the Acting Director. ADDRESSES: You may submit comments about this policy although USCIS is not officially requesting public comments. To ensure that your comments and related materials are not entered more than once in the docket, please submit VerDate Aug<31>2005 21:01 Jun 30, 2008 Jkt 214001 them by only one of the following methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. • Mail: Chief, Regulatory Management Division, U.S. Citizenship and Immigration Services, Department of Homeland Security, 111 Massachusetts Avenue, NW., Suite 3008, Washington, DC 20529. To ensure proper handling, please reference DHS Docket No. USCIS–2008–0031 on your correspondence. This mailing address may also be used for paper, disk, or CD– ROM submissions. • Hand Delivery/Courier: Regulatory Management Division, U.S. Citizenship and Immigration Services, Department of Homeland Security, 111 Massachusetts Avenue, NW., Suite 3008, Washington, DC 20529. Contact Telephone Number (202) 272–8377. FOR FURTHER INFORMATION CONTACT: Christine Gooding, Customer Assistance Office, U.S. Citizenship and Immigration Services, 111 Massachusetts Ave., NW., 6th Floor, Washington, DC 20539; Phone: 1–800– 357–2099 SUPPLEMENTARY INFORMATION: The National Ombudsman of the U.S. Small Business Administration (SBA) has asked each Federal agency to adopt a policy that the agency will not retaliate against small businesses that question or complain about the way the agency does business. On June 24, 2008, the Acting Director of U.S. Citizenship and Immigration Services (USCIS) approved the following statement of USCIS policy: If a small business questions or complains about a U.S. Citizenship and Immigration Services policy or action or seeks help from others to deal with a USCIS policy or action, USCIS will not retaliate against that small business in any way. If a small business thinks that USCIS has not followed this policy, the agency will investigate, take appropriate action, and ensure that mistakes are not repeated. Small businesses may comment, ask questions, or file a complaint about USCIS policies or actions by contacting the USCIS Customer Assistance Office, local USCIS offices, or the Small Business Administration’s Office of the National Ombudsman at 1–888–REG–FAIR (734– 3247), fax 202–481–5719; e-mail ombudsman@sba.gov. Small businesses generally are independently owned and operated and are not dominant in their fields. If you need help determining whether or not your business qualifies as a ‘‘small business,’’ contact the SBA’s Office of PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 the National Ombudsman using the information as noted above. Dated: June 24, 2008. Jonathan R. Scharfen, Acting Director, U.S. Citizenship and Immigration Services. [FR Doc. E8–14843 Filed 6–30–08; 8:45 am] BILLING CODE 9111–97–P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service [FWS–R6–ES–2008–N0159; 60120–1113– 0000–D2] Endangered and Threatened Wildlife and Plants; Permits Fish and Wildlife Service, Interior. ACTION: Notice of receipt of applications for permits. AGENCY: SUMMARY: We announce our receipt of applications to conduct certain activities pertaining to enhancement of survival of endangered species. DATES: Written comments on this request for a permit must be received by July 31, 2008. ADDRESSES: Written data or comments should be submitted to the Assistant Regional Director, Fisheries—Ecological Services, U.S. Fish and Wildlife Service, P.O. Box 25486, Denver Federal Center, Denver, Colorado 80225–0486; facsimile 303–236–0027. Before including your address, phone number, e-mail address, or other personal indentifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. Documents and other information submitted with these applications are available for review, subject to the requirements of the Privacy Act [5 U.S.C. 552A] and Freedom of Information Act [5 U.S.C. 552], by any party who submits a request for a copy of such documents within 30 days of the date of publication of this notice to Kris Olsen, by mail or by telephone at 303–236–4256. All comments received from individuals become part of the official public record. The following applicants have requested issuance of enhancement of survival permits to conduct certain activities SUPPLEMENTARY INFORMATION: E:\FR\FM\01JYN1.SGM 01JYN1

Agencies

[Federal Register Volume 73, Number 127 (Tuesday, July 1, 2008)]
[Notices]
[Pages 37469-37470]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-14839]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special

[[Page 37470]]

Emphasis Panel; Operation of a Facility for the Study of Infectious 
Agents, Vaccines and Antimicrobials in Adult and Pediatric Human 
Subjects.
    Date: July 21, 2008.
    Time: 9 a.m. to 12 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Lynn Rust, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 20892, 301-402-3938, lr228v@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: June 24, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-14839 Filed 6-30-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.